Home
Scholarly Works
Real-world utilization of the new fixed-dose...
Conference

Real-world utilization of the new fixed-dose combination elbasvir/grazoprevir in adult patients with chronic hepatitis C in Canada: Z-PROFILE study

Authors

Tam E; Fraser C; Tremblay J; Conway B; Trottier B; Ramji A; Borgia S; Stewart K; Trepanier J; Chalabi Y

Volume

66

Pagination

pp. S307-S308

Publisher

ELSEVIER SCIENCE BV

Publication Date

January 1, 2017

Name of conference

International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver

Conference place

Amsterdam, NETHERLANDS

Conference start date

April 19, 2017

Conference end date

April 23, 2017

Conference proceedings

JOURNAL OF HEPATOLOGY

Issue

1

ISSN

0168-8278

Labels

Fields of Research (FoR)

Contact the Experts team